You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Dr. Isis notes, with some nervousness, that she has had an unanticipated, enormous response to participate in her clinical trial and wonders if the current economic climate is contributing to the interest in her project. Zuska adds that she wouldn't be surprised if that were the reason.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.